Literature DB >> 9071265

The doctor and the migraine patient: improving compliance.

E A MacGregor1.   

Abstract

Migraine is an underdiagnosed and undertreated disorder. This can be attributed to the low consultation rate for migraine, for which many reasons have been proposed. These include the fact that many migraineurs self-treat and, historically, the lack of available effective treatments. Some migraineurs are referred to specialist centers for advice. These patients do not merely need effective pain relief. They also need an explanation of the cause of the migraine and reassurance that their headache pain does not have a more sinister cause. By spending time with patients and taking a full history of their migraine condition, the physician can propose a management strategy that is appropriate to each individual patient, thus providing a tailored-care approach. Thorough exploration of possible trigger factors for migraine and advice on avoidance may help to reduce attack frequency. Simple techniques can also be used to improve compliance with prescribed therapies. For example, it is important for the physician to establish that the patient understands any instructions given and to reinforce this advice at follow-up visits. Regular follow-up is important because it enables management strategies to be evaluated and helps the patients to feel involved in the management of their migraine. A correct understanding of the way a drug works and the nature of the condition, together with an explanation of any potential side effects, is likely to maximize clinical benefit.

Entities:  

Mesh:

Year:  1997        PMID: 9071265     DOI: 10.1212/wnl.48.3_suppl_3.16s

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Perceptions and needs of patients with migraine: a focus group study.

Authors:  Constance K Cottrell; Jana B Drew; Sharon E Waller; Kenneth A Holroyd; John A Brose; Francis J O'Donnell
Journal:  J Fam Pract       Date:  2002-02       Impact factor: 0.493

2.  Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.

Authors:  David Dodick; Jan Brandes; Arthur Elkind; Ninan Mathew; Lawrence Rodichok
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 3.  Patient perceptions and treatment preferences in migraine management.

Authors:  David Dodick
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Impact of physician empathy on migraine disability and migraineur compliance.

Authors:  Hatim S Attar; Srinath Chandramani
Journal:  Ann Indian Acad Neurol       Date:  2012-08       Impact factor: 1.383

5.  Improved migraine management in primary care: results of a patient treatment experience study using zolmitriptan orally disintegrating tablet.

Authors:  G Shapero; A Dowson; J-P Lacoste; P Almqvist
Journal:  Int J Clin Pract       Date:  2006-12       Impact factor: 2.503

6.  Difficult to swallow: patient preferences for alternative valproate pharmaceutical formulations.

Authors:  Monali Bhosle; Joshua S Benner; Mitch Dekoven; Jeff Shelton
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

7.  Noncompliance in neurologic patients.

Authors:  David B Weiss; Thomas P Beresford; Robert M House
Journal:  Curr Treat Options Neurol       Date:  2005-09       Impact factor: 3.972

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.